Skip to content
HowShorted

Puma Biotechnology Inc short interest in 2023

In 2023, Puma Biotechnology Inc's disclosed short interest ran from 2.05% of shares outstanding on 13 Jan 2023 to 6.09% on 29 Dec 2023, a change of +4.04 percentage points. The year's high was 6.09% on 29 Dec 2023 and its low 2.05% on 13 Jan 2023, averaging 3.40% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.92 days on 31 Oct 2023. Full history: Puma Biotechnology Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Puma Biotechnology Inc in 2023

2023 in figures

Start of year
2.05% (13 Jan 2023)
End of year
6.09% (29 Dec 2023)
Change
+4.04 pp
High
6.09% (29 Dec 2023)
Low
2.05% (13 Jan 2023)
Average
3.40%
Highest days to cover
18.92 (31 Oct 2023)
SEC filings marked
8

Every report in 2023

Puma Biotechnology Inc short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20232.05%2.17
31 Jan 20232.30%4.49
15 Feb 20232.45%3.97
28 Feb 20232.51%5.45
15 Mar 20232.62%2.4910-K filed, results (8-K)
31 Mar 20232.84%2.90
14 Apr 20232.82%5.32
28 Apr 20233.02%7.98
15 May 20232.91%6.1710-Q filed, results (8-K)
31 May 20232.92%5.66
15 Jun 20233.07%6.30
30 Jun 20233.43%6.69
14 Jul 20233.56%6.85
31 Jul 20233.41%12.47
15 Aug 20233.44%8.6510-Q filed, results (8-K)
31 Aug 20233.52%12.63
15 Sep 20233.64%13.55
29 Sep 20233.68%14.36
13 Oct 20233.66%15.76
31 Oct 20233.62%18.92
15 Nov 20233.96%5.4710-Q filed, results (8-K)
30 Nov 20234.29%6.61
15 Dec 20235.81%10.17
29 Dec 20236.09%11.06

See also: Puma Biotechnology Inc's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.